国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2008年
4期
314,317
,共2页
金黄杆菌属%抗药性,细菌%β内酰胺酶类
金黃桿菌屬%抗藥性,細菌%β內酰胺酶類
금황간균속%항약성,세균%β내선알매류
Chryseobacterium%Drug resistance,Bacterial%beta Lactamases
目的 了解我院脑膜炎败血性金黄杆菌的分布和耐药性.方法 统计分析我院近5年来分离的73株脑膜炎败血性金黄杆菌的耐药情况;用双纸片协同试验筛选金属β-内酰胺酶.结果 脑膜炎败血性金黄杆菌产金属β-内酰胺酶为37.0%,主要分布在重症监护(ICU)病房,哌拉西林/他唑巴坦、万古霉素和利福平耐药率较低,分别为45.2%、40.6%和28.5%.结论 脑膜炎败血性金黄杆菌表现为多重耐药,临床医师应根据药敏试验合理选择抗菌药物.
目的 瞭解我院腦膜炎敗血性金黃桿菌的分佈和耐藥性.方法 統計分析我院近5年來分離的73株腦膜炎敗血性金黃桿菌的耐藥情況;用雙紙片協同試驗篩選金屬β-內酰胺酶.結果 腦膜炎敗血性金黃桿菌產金屬β-內酰胺酶為37.0%,主要分佈在重癥鑑護(ICU)病房,哌拉西林/他唑巴坦、萬古黴素和利福平耐藥率較低,分彆為45.2%、40.6%和28.5%.結論 腦膜炎敗血性金黃桿菌錶現為多重耐藥,臨床醫師應根據藥敏試驗閤理選擇抗菌藥物.
목적 료해아원뇌막염패혈성금황간균적분포화내약성.방법 통계분석아원근5년래분리적73주뇌막염패혈성금황간균적내약정황;용쌍지편협동시험사선금속β-내선알매.결과 뇌막염패혈성금황간균산금속β-내선알매위37.0%,주요분포재중증감호(ICU)병방,고랍서림/타서파탄、만고매소화리복평내약솔교저,분별위45.2%、40.6%화28.5%.결론 뇌막염패혈성금황간균표현위다중내약,림상의사응근거약민시험합리선택항균약물.
Objective To investigate the distribution and drug resistance of Chryseobacterium meningosepticum(CM)in our hospital.Methods The status of drug resistance of 73 strains of CM isolated from our hospital in the past 5 years was statistically analyzed.Metallo-β-lactamase producing isolates were screened by double-disk synergy test.Results The rate of metallo-β-laetamase producing Chryseobacterium meningosepticum(CM) accounted for 37.0%,which mainly distributed at intensive care unit(ICU).The resistant rates of CM clinical isolates to piperacillin/tazobactam,vancomycin and levofloxacin were 45.2%,40.6% and 28.5%,respectively.Conclusion CM displays multi-resistance to antibiotics.Antimicrobial agents should be selected rationally by clinicians according to antimicrobial susceptibility test results.
